![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of Elbasvir and Grazoprevir with or without Ribavirin for the Treatment of HCV Genotype 1: Results of the HCV-TARGET Study
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Pearlman, BL; Lutchman, G; Shiffman, ML; Patel, J; Frazier, LM; Galati, JS; Gallant, JE; Ramani, A; Vainorius, M; Nelson, DR; Fried, MW; Dong, M; Khalili, M; Ben-Ari, Z
![EASL1](../images/050217/050217-4/EASL1.gif)
![EASL2](../images/050217/050217-4/EASL2.gif)
![EASL3](../images/050217/050217-4/EASL3.gif)
![EASL4](../images/050217/050217-4/EASL4.gif)
![EASL5](../images/050217/050217-4/EASL5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|